Equities

AVE Science & Technology Co Ltd

688067:SHH

AVE Science & Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)17.97
  • Today's Change-0.36 / -1.96%
  • Shares traded1.62m
  • 1 Year change-26.50%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year AVE Science & Technology Co Ltd had relatively flat revenues (196.77m to 200.31m), though the company grew net income 19.81% from 17.97m to 21.53m. A reduction in the cost of goods sold as a percentage of sales from 46.33% to 43.14% was a component in the net income growth despite flat revenues.
Gross margin56.73%
Net profit margin11.13%
Operating margin11.67%
Return on assets4.10%
Return on equity4.55%
Return on investment4.46%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at AVE Science & Technology Co Ltd fell by 67.08m. However, the company earned 22.73m from its operations for a Cash Flow Margin of 11.35%. In addition the company used 83.00m on investing activities and also paid 6.80m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share7.35
Tangible book value per share7.02
More ▼

Balance sheet in CNYView more

AVE Science & Technology Co Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio6.56
Quick ratio5.51
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in CNY

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 19.81%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)30.14%
EPS growth(5 years)-4.62
EPS (TTM) vs
TTM 1 year ago
23.85
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.